0 New trials a game-changer for latent TB treatment
Clinical trial data has proved a novel, short therapy more effective and safe for the treatment of latent tuberculosis than the standard therapy in both adults and children.
Browsing: Bacterial > Tuberculosis
0 Neurotuberculosis, from treatment to politics – an interview with Guy Thwaites
Guy Thwaites, Director of the Oxford University Clinical Research Unit/Wellcome Program in Vietnam, speaks on neurotuberculosis and the challenges it faces in terms of treatment, HIV co-infection and the political will necessary for change.
0 A peek behind the paper – better than a pound of cure; steps to prevent multidrug resistant tuberculosis in adults and children
Take a look behind the science of a recent Future Microbiology article, entitled ‘Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis’ as we ask the authors about the challenges currently facing multidrug resistant (MDR) tuberculosis and what the future might hold.
0 In focus: Tuberculosis
World Tuberculosis Day 2018 (March 24th) is an annual event aiming to raise public awareness around the health, economic and…
0 N-TB – first-of-kind app launched for nutritional assessment and counselling of tuberculosis patients
World TB Day has seen the launch of the N-TB app, a first-of-kind tool to help healthcare providers in the nutritional assessment and counselling of adult patients with tuberculosis.
0 HIV and TB: the ongoing challenge of the two epidemics
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
0 #TalkTB – Catch up on the Twitter chat for World TB Day
We look at some of the highlights of our Twitter chat (#TalkTB), where we questioned Madhukar Pai, Nandita Venkatesan and Jacob Creswell about all things tuberculosis – from diagnosis to social stigma.
0 Infographic: The pipeline for tuberculosis diagnostics
In this infographic we take a look at the diagnostics currently in the pipeline for tuberculosis, highlighting the stage of development and intended use.
1 Twitter chat for World TB Day #TalkTB
Join us for our Twitter chat with experts in the field on the 21st March at 11:00 EST / 15:00 GMT, discussing tuberculosis, its elimination and the challenges that face it #TalkTB.
0 Promising data for dolutegravir and HIV combination therapy GS-9620 and PGT121: industry news round-up
Partnership announcements and promising trial data reported at the 2018 Conference on Retroviruses and Opportunistic Infections, take a look at our round-up of the latest industry headlines.
